Global Enteral Single Use Syringes Market Size By Type (1 ml, 3 ml), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Enteral Single Use Syringes Market was valued at USD 1.3 billion in 2023 and is projected to surpass USD 2.2 billion by 2031, growing at a CAGR of 6.7% during the forecast period of 2023–2031. The market is primarily driven by the rising incidence of chronic illnesses requiring long-term nutritional support, growing awareness around enteral feeding safety, and increasing demand for hygienic, cost-effective feeding solutions in hospitals and home care settings. Enteral single use syringes are increasingly adopted to prevent cross-contamination and reduce the risk of infections in vulnerable patient groups such as neonates, geriatric populations, and individuals undergoing critical care.

Drivers:

Rising Prevalence of Chronic and Acute Conditions

Patients suffering from conditions such as cancer, gastrointestinal disorders, and neurological impairments increasingly require enteral feeding for nutritional management. This trend is driving the demand for single-use enteral syringes that ensure sterile, controlled, and safe administration of nutritional formulas.

Stringent Regulations on Infection Control

Healthcare regulations focusing on infection prevention have significantly boosted the adoption of disposable medical devices, including enteral syringes. Compliance with ISO standards and ENFit™ connector mandates further supports market expansion.

Shift Towards Home Enteral Nutrition (HEN)

The shift from institutional to home-based care is encouraging the use of easy-to-use, single-use enteral syringes, particularly for pediatric and elderly patients. The demand is also strengthened by reimbursement frameworks in developed markets.

Restraints:

Environmental Concerns over Plastic Waste

Single-use syringes contribute to medical plastic waste, which has raised sustainability concerns. Regulatory pressures and growing advocacy for eco-friendly alternatives may affect the market growth trajectory unless recyclable or biodegradable solutions are developed.

Cost Sensitivity in Low-Income Regions

While essential, single-use syringes face adoption challenges in cost-sensitive markets, where reuse and lower-priced traditional feeding tools are more common.

Opportunity:

Product Innovation and Eco-friendly Materials

Manufacturers are investing in the development of biodegradable and recyclable syringe materials to align with environmental goals. This innovation opens avenues for expansion in both developed and environmentally-conscious markets.

Emerging Economies and Home Healthcare Expansion

Asia-Pacific and Latin America are witnessing rapid improvements in healthcare infrastructure and increased government initiatives promoting nutritional care, which creates untapped potential for enteral syringe manufacturers.

Market by System Type Insights:

By system type, ENFit™ syringes held the dominant market share in 2023. Their standardized design reduces misconnections with intravenous or luer-based systems, enhancing safety. ENFit™ products are increasingly mandated across North America and Europe, supporting consistent market demand. The Legacy Enteral Syringes segment, although declining, still retains relevance in less regulated or transitioning markets.

Market by End-use Insights:

In 2023, the Hospitals segment accounted for the largest revenue share, driven by the high volume of acute care patients requiring safe and sterile enteral feeding. However, the Home Care Settings segment is expected to witness the fastest growth rate, owing to the rise in outpatient nutritional therapy and patient preference for at-home recovery post-surgery or during chronic illness management.

Market by Regional Insights:

North America dominated the global enteral single use syringes market in 2023, supported by stringent safety regulations, widespread adoption of ENFit™ connectors, and a strong presence of healthcare manufacturers. Asia-Pacific is forecast to experience the highest CAGR, driven by increasing healthcare access, rising awareness of nutritional therapy, and government support for medical device safety standards.

Competitive Scenario:

Key players in the Global Enteral Single Use Syringes Market include:

Cardinal Health, Inc.

BD (Becton, Dickinson and Company)

Vygon Group

Medela AG

Baxter International Inc.

GBUK Group Ltd

Kentec Medical, Inc.

Vesco Medical LLC

These companies are focused on product innovation, regulatory compliance (e.g., ENFit™), and expansion into emerging markets to enhance their global footprint. For example:

2023: Vygon Group launched a new line of eco-designed enteral syringes using recyclable materials.

2024: BD expanded its manufacturing facility in the U.S. to meet increasing demand for single-use nutritional devices.

2025: Cardinal Health announced a partnership with a home healthcare provider to streamline distribution of enteral nutrition kits.

Scope of Work – Global Enteral Single Use Syringes Market

Report Metric Details

Market Size (2023) USD 1.3 billion

Projected Market Size (2031) USD 2.2 billion

CAGR (2023–2031) 6.7%

Market Segments System Type (ENFit™, Legacy), End-use, Region

Growth Drivers Rising chronic illness prevalence, safety regulations, HEN growth

Opportunities Sustainable products, emerging market expansion

Key Market Developments:

2023: Vygon Group launched recyclable ENFit™ enteral syringes targeting EU markets with high sustainability benchmarks.

2024: BD invested USD 50 million in R&D for